HYPOTENSIVE AND HYPERTENSIVE AGENTS: MECHANISMS, DOSE–RESPONSE RELATIONSHIPS, CLINICAL USE, ADVERSE EFFECTS, AND SAFETY PRINCIPLES

ASL MANBA
Ushbu maqola dastlab XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR nomli respublika ilmiy-amaliy konferensiyasi jurnalida nashr etilgan.

o‘g‘li, Amonov Botirali Baxrom, Abdurakhmonovna, Kibriyeva Maxfirat (2026) HYPOTENSIVE AND HYPERTENSIVE AGENTS: MECHANISMS, DOSE–RESPONSE RELATIONSHIPS, CLINICAL USE, ADVERSE EFFECTS, AND SAFETY PRINCIPLES. XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR nomli respublika ilmiy-amaliy konferensiyasi.

To'liq matn arxivda mavjud emas — maqolaning asl manbasiga havola pastda berilgan.

Annotatsiya

Arterial blood pressure is determined by cardiac output and peripheral vascular resistance; these parameters are finely regulated through the renin–angiotensin–aldosterone system, the sympathetic nervous system, renal sodium–water handling, and endothelial mediators. For this reason, the pharmacology of hypotensive (blood-pressure–lowering) and hypertensive (blood-pressure–raising, pressor) agents cannot be reduced to the simple idea of “lowering or raising the number”: such agents influence the heart, kidneys, brain, and peripheral vessels through different pathways and serve distinct goals in acute and chronic clinical settings

Hujjat turi: Maqola
Mualliflar:
Muallif
Email
o‘g‘li, Amonov Botirali Baxrom
UNSPECIFIED
Abdurakhmonovna, Kibriyeva Maxfirat
UNSPECIFIED
Jurnal / Nashr: XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR nomli respublika ilmiy-amaliy konferensiyasi
Nashriyot: "XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR" nomli respublika ilmiy-amaliy konferensiyasi
Sana: 23 Fevral 2026
DOI / ID: oai:ojs.pkp.sfu.ca:article/16816
Kalit so'zlar: arterial hypertension, hypotensive agents, vasopressors, inotropic drugs, RAAS, beta-blocker, ACE inhibitor, ARB, calcium channel blocker, safety and monitoring
Mavzular: ?? arterial hypertension, hypotensive agents, vasopressors, inotropic drugs, RAAS, beta-blocker, ACE inhibitor, ARB, calcium channel blocker, safety and monitoring ??
Eslatma: Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/16816)
URI: https://arxiv.universalpublishings.com/id/eprint/71112
Amallar
[pin missing: title]
[pin missing: title]